G Medical Innovations Holdings (G Medical Innovations Holdings) Buyback Yield % : -902.45 (As of Jun. 10, 2024)

View and export this data going back to 2017. Start your Free Trial

What is G Medical Innovations Holdings Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

G Medical Innovations Holdings's current buyback yield was -902.45%.

G Medical Innovations Holdings Buyback Yield % Historical Data

The historical data trend for G Medical Innovations Holdings's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G Medical Innovations Holdings Buyback Yield % Chart

G Medical Innovations Holdings Annual Data

Trend

Sep16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Buyback Yield %

Get a 7-Day Free Trial

-0.01

-59.17

-66.06

G Medical Innovations Holdings Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
Buyback Yield %	Get a 7-Day Free Trial							-0.01	-54.29	-0.03	-45.26	0.72

Competitive Comparison of G Medical Innovations Holdings's Buyback Yield %

For the Medical Instruments & Supplies subindustry, G Medical Innovations Holdings's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

G Medical Innovations Holdings's Buyback Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, G Medical Innovations Holdings's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where G Medical Innovations Holdings's Buyback Yield % falls into.

G Medical Innovations Holdings Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

G Medical Innovations Holdings's Buyback Yield for the fiscal year that ended in Dec. 2022 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (-0.121	+	3.442)	/	5.0275512
	=	-66.06%

G Medical Innovations Holdings's annualized Buyback Yield for the quarter that ended in Dec. 2022 is calculated as

Buyback Yield	=	Net Issuance of Stock		(Annualized)			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	*	Annualized Factor	/	Market Cap
	=	- (0	+	-0.018)	*	2	/	5.0275512
	=	0.72%

In calculating the annualized semi-annual data, the Repurchase of Stock and Issuance of Stock data used here is two times the semi-annual (Dec. 2022) data.

G Medical Innovations Holdings Buyback Yield % Related Terms

Thank you for viewing the detailed overview of G Medical Innovations Holdings's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

G Medical Innovations Holdings (G Medical Innovations Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » G Medical Innovations Holdings Ltd (OTCPK:GMVDF) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

5 Oppenheimer Street, Rehovot, ISR, 7670105

Website

https://www.gmedinnovations.com

G Medical Innovations Holdings Ltd is a mobile health (mHealth), telemedicine solutions, and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. The company offers a suite of both consumer and clinical grade products and platforms which are positioned to reduce inefficiencies in healthcare delivery, improve access, reduce costs, increase the quality of care, and make healthcare more personalized and precise. Its operating segment includes Products, Patient Services, and Covid-19 testing. The company generates maximum revenue from the Patient Services segment.

Executives

Awm Investment Company, Inc.

10 percent owner

527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022